VanEck Vectors Pharmaceutical ETF (PPH)

Delayed Data
As of Mar 23
 -0.85 / -1.51%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to replicate as closely as possible- before fees and expenses- the price and yield performance of the MVIS- US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

No recent news for VanEck Vectors Pharmaceutical ETF.


1 month-5.34% 3 years-6.01%
3 months-5.31% 5 years+6.95%
1 year+3.82% Since inception+9.73%
Data through 03/23/2018

Quote Details

Previous close$56.22
Open day’s range55.28 – 56.51
Net asset value (NAV)56.22 (03/22/2018)
Daily volume11,854
Average volume (3 months)124,618
Data as of 4:00pm ET, 03/23/2018

Peer Comparisonvs. Health ETFs

Performance 5-yr return+6.95%+17.28%
Expense Gross exp ratio0.40%1.30%
Risk 5 year sharpe ratio0.631.02
Net assets$259.5M$3.1B
Average market cap$46.6B$10.4B
Average P/E15.622.9
Dividend / Share--0.34%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
ABBV AbbVie6.01%
TEVA Teva Pharmaceutical5.91%
BMY Bristol-Myers Squibb5.37%
GSK GlaxoSmithKline5.17%
AZN AstraZeneca5.12%
ZTS Zoetis Inc5.08%
PFE Pfizer4.99%
NVS Novartis4.93%
MYL Mylan NV4.93%
MRK Merck4.92%